Ken Cassidy

Ken Cassidy is an Executive Director at Eli Lilly and Company, where they have been involved in pharmaceutical research with a focus on ADME and biotransformation since 2000. Previously, Ken held roles including Research Scientist at Rhone-Poulenc Rorer and Research Scientist at Eli Lilly Canada, where they developed bioanalytical laboratory methods. Ken earned a BSc Honors in Chemistry and a Ph.D. in Organic Chemistry from the University of Windsor, followed by a postdoctoral fellowship at The Scripps Research Institute. With extensive expertise in LC/MS bioanalysis and drug metabolism, Ken leads projects aimed at optimizing ADME properties and authoring IND and IB sections.